178 research outputs found

    Π’Π›Π˜Π―ΠΠ˜Π• ΠŸΠΠ ΠΠœΠ•Π’Π ΠžΠ’ ΠŸΠžΠ’Π•ΠΠ¦Π˜ΠΠ›Π Π‘ΠœΠ•Π©Π•ΠΠ˜Π― И ΠžΠ Π˜Π•ΠΠ’ΠΠ¦Π˜Π˜ ΠŸΠžΠ”Π›ΠžΠ–ΠšΠ˜ НА Π₯ΠΠ ΠΠšΠ’Π•Π Π˜Π‘Π’Π˜ΠšΠ˜ ΠžΠ‘ΠΠ–Π”ΠΠ•ΠœΠžΠ“Πž ПОКРЫВИЯ: Π ΠžΠ›Π¬ Π ΠΠ‘ΠŸΠ«Π›Π•ΠΠ˜Π―

    Get PDF
    ВСорСтичСски исслСдуСтся влияниС процСссов Π°Ρ‚ΠΎΠΌΠ½ΠΎΠ³ΠΎ распылСния Π½Π° Π²Π΅Π»ΠΈΡ‡ΠΈΠ½Ρƒ Π²Π½ΡƒΡ‚Ρ€Π΅Π½Π½ΠΈΡ… напряТСний ΠΈ ΡΠΊΠΎΡ€ΠΎΡΡ‚ΡŒ роста покрытия, ΠΏΠΎΠ»ΡƒΡ‡Π°Π΅ΠΌΠΎΠ³ΠΎ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠΌ ΠΏΠ»Π°Π·ΠΌΠ΅Π½Π½ΠΎ-ΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ осаТдСния с использованиСм ΠΈΠΌΠΏΡƒΠ»ΡŒΡΠ½ΠΎΠ³ΠΎ ΠΏΠΎΡ‚Π΅Π½Ρ†ΠΈΠ°Π»Π° смСщСния Π½Π°Β ΠΏΠΎΠ΄Π»ΠΎΠΆΠΊΠ΅ ΠΈ ΠΏΡ€ΠΈ Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… ΡƒΠ³Π»Π°Ρ… падСния ΠΈΠΎΠ½ΠΎΠ² Π½Π° ΠΎΡΠ°ΠΆΠ΄Π°Π΅ΠΌΡƒΡŽ ΠΏΠΎΠ²Π΅Ρ€Ρ…Π½ΠΎΡΡ‚ΡŒ. Π€ΠΎΡ€ΠΌΡƒΠ»Π° для расчСта Π²Π½ΡƒΡ‚Ρ€Π΅Π½Π½ΠΈΡ… напряТСний в осаТдаСмом ΠΏΠΎΠΊΡ€Ρ‹Ρ‚ΠΈΠΈ, получСнная Π² Ρ€Π°ΠΌΠΊΠ°Ρ… ΠΌΠΎΠ΄Π΅Π»ΠΈ нСлокального Ρ‚Π΅Ρ€ΠΌΠΎΡƒΠΏΡ€ΡƒΠ³ΠΎΠ³ΠΎ ΠΏΠΈΠΊΠ° ΠΈΠΎΠ½Π° с ΡƒΡ‡Π΅Ρ‚ΠΎΠΌ процСссов атомного распылСния, использовалась для расчСта напряТСний Π² покрытиях TiN ΠΈ CrN, осаТдаСмых ΠΈΠ· ΠΏΠΎΡ‚ΠΎΠΊΠΎΠ² ΠΈΠΎΠ½ΠΎΠ² Ti+ ΠΈ Cr+, соотвСтствСнно. Π’Π΅Π»ΠΈΡ‡ΠΈΠ½Π° напряТСний для рассмотрСнных ΠΏΠΎΠΊΡ€Ρ‹Ρ‚ΠΈΠΉ ΠΊΠΎΡ€Ρ€Π΅Π»ΠΈΡ€ΡƒΠ΅Ρ‚ с ΠΌΠΎΠ΄ΡƒΠ»Π΅ΠΌ упругости матСриала покрытия. ΠœΠ°ΠΊΡΠΈΠΌΡƒΠΌ ΠΊΡ€ΠΈΠ²ΠΎΠΉ напряТСний ΡƒΠΌΠ΅Π½ΡŒΡˆΠ°Π΅Ρ‚ΡΡ ΠΈ смСщаСтся Π² ΠΎΠ±Π»Π°ΡΡ‚ΡŒ Π±ΠΎΠ»Π΅Π΅ высоких ΠΏΠΎΡ‚Π΅Π½Ρ†ΠΈΠ°Π»ΠΎΠ² с ростом угла падСния. Π’Π°ΠΊΠΎΠ΅ ΠΏΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ обусловлСно процСссом распылСния ΠΊΠ²Π°Π·ΠΈΡΡ‚Π°Π±ΠΈΠ»ΡŒΠ½Ρ‹Ρ… ΠΌΠ΅ΠΆΠ΄ΠΎΡƒΠ·Π΅Π»ΡŒΠ½Ρ‹Ρ… Π΄Π΅Ρ„Π΅ΠΊΡ‚ΠΎΠ², ΠΎΠΏΡ€Π΅Π΄Π΅Π»ΡΡŽΡ‰ΠΈΡ…Β ΡƒΡ€ΠΎΠ²Π΅Π½ΡŒ напряТСний Π² осаТдаСмом ΠΏΠΎΠΊΡ€Ρ‹Ρ‚ΠΈΠΈ. ΠŸΡ€Π΅Π΄Π»ΠΎΠΆΠ΅Π½Π° Ρ„ΠΎΡ€ΠΌΡƒΠ»Π° для скорости осаТдСния покрытия, ΡƒΡ‡ΠΈΡ‚Ρ‹Π²Π°ΡŽΡ‰Π°ΡΒ Ρ€Π°ΡΠΏΡ‹Π»Π΅Π½ΠΈΠ΅ Π°Ρ‚ΠΎΠΌΠΎΠ² покрытия ΠΏΡ€ΠΈ ΠΏΡ€ΠΎΠΈΠ·Π²ΠΎΠ»ΡŒΠ½Ρ‹Ρ… ΠΏΠΎΡ‚Π΅Π½Ρ†ΠΈΠ°Π»Π΅ смСщСния ΠΈ ΡƒΠ³Π»Π΅ падСния ΠΈΠΎΠ½ΠΎΠ². Показано, Ρ‡Ρ‚ΠΎ распылСниС рСзко сниТаСт ΡΠΊΠΎΡ€ΠΎΡΡ‚ΡŒ осаТдСния ΠΏΠΎΠΊΡ€Ρ‹Ρ‚ΠΈΠΉ ΠΈ Π΄Π΅Π»Π°Π΅Ρ‚ Π½Π΅Π²ΠΎΠ·ΠΌΠΎΠΆΠ½Ρ‹ΠΌ осаТдСниС ΠΏΠΎΠΊΡ€Ρ‹Ρ‚ΠΈΠΉ TiN ΠΈ CrN Π² Ρ€Π΅ΠΆΠΈΠΌΠ΅ постоянного потСнциала ΠΏΡ€ΠΈ ΠΏΠΎΡ‚Π΅Π½Ρ†ΠΈΠ°Π»Π°Ρ… Π½Π° ΠΏΠΎΠ΄Π»ΠΎΠΆΠΊΠ΅, ΠΏΡ€Π΅Π²Ρ‹ΡˆΠ°ΡŽΡ‰ΠΈΡ… 1,7 ΠΊΠ’ ΠΈ 0,7 ΠΊΠ’, соотвСтствСнно, ΠΈ ΠΏΡ€ΠΈ Π½ΠΎΡ€ΠΌΠ°Π»ΡŒΠ½ΠΎΠΌ ΠΏΠ°Π΄Π΅Π½ΠΈΠΈΒ ΠΈΠΎΠ½ΠΎΠ². РаспылСниС ΠΎΠΊΠ°Π·Ρ‹Π²Π°Π΅Ρ‚ наибольшСС влияниС Π½Π° Π²Π½ΡƒΡ‚Ρ€Π΅Π½Π½Π΅Π΅ напряТСниС ΠΈ ΡΠΊΠΎΡ€ΠΎΡΡ‚ΡŒ роста покрытия ΠΏΡ€ΠΈ осаТдСнии ионов ΠΏΠΎΠ΄ Π½Π°ΠΊΠ»ΠΎΠ½Π½Ρ‹ΠΌΠΈ ΡƒΠ³Π»Π°ΠΌΠΈ падСния Ξ± = 45Β°...70Β° . Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ расчСтов ΡΡ€Π°Π²Π½ΠΈΠ²Π°ΡŽΡ‚ΡΡ с ΠΈΠΌΠ΅ΡŽΡ‰ΠΈΠΌΠΈΡΡΒ ΡΠΊΡΠΏΠ΅Ρ€ΠΈΠΌΠ΅Π½Ρ‚Π°Π»ΡŒΠ½Ρ‹ΠΌΠΈ Π΄Π°Π½Π½Ρ‹ΠΌΠΈ

    Decoration of nanovesicles with pH (low) insertion peptide (pHLIP) for targeted delivery

    Get PDF
    Acidity at surface of cancer cells is a hallmark of tumor microenvironments, which does not depend on tumor perfusion, thus it may serve as a general biomarker for targeting tumor cells. We used the pH (low) insertion peptide (pHLIP) for decoration of liposomes and niosomes. pHLIP senses pH at the surface of cancer cells and inserts into the membrane of targeted cells, and brings nanomaterial to close proximity of cellular membrane. DMPC liposomes and Tween 20 or Span 20 niosomes with and without pHLIP in their coating were fully characterized in order to obtain fundamental understanding on nanocarrier features and facilitate the rational design of acidity sensitive nanovectors. The samples stability over time and in presence of serum was demonstrated. The size, ΞΆ-potential, and morphology of nanovectors, as well as their ability to entrap a hydrophilic probe and modulate its release were investigated. pHLIP decorated vesicles could be useful to obtain a prolonged (modified) release of biological active substances for targeting tumors and other acidic diseased tissues

    The place of intravenous immunoglobulin in rheumatic diseases

    Get PDF
    Therapy with intravenous human immunoglobulin (IVIG) was and continues to remain essential for a number of diseases. At the same time the evidence base for IVIG use is extremely small in rheumatology. Clinical experience shows that IVIG is effective in treating thrombocytopenic purpura, Guillain–Barre syndrome, and chronic inflammatory demyelinating polyneuropathy, which develop in the presence of rheumatic diseases, such as systemic lupus erythematosus, inflammatory myopathies, and antineutrophil cytoplasmic antibody-associated vasculitides. The review considers indications for the use of IVIG, its dosage regimen, benefits, and adverse reactions and analyzes the Russian and foreign literature on this issue

    BRST approach to Lagrangian formulation for mixed-symmetry fermionic higher-spin fields

    Full text link
    We construct a Lagrangian description of irreducible half-integer higher-spin representations of the Poincare group with the corresponding Young tableaux having two rows, on a basis of the BRST approach. Starting with a description of fermionic higher-spin fields in a flat space of any dimension in terms of an auxiliary Fock space, we realize a conversion of the initial operator constraint system (constructed with respect to the relations extracting irreducible Poincare-group representations) into a first-class constraint system. For this purpose, we find auxiliary representations of the constraint subsuperalgebra containing the subsystem of second-class constraints in terms of Verma modules. We propose a universal procedure of constructing gauge-invariant Lagrangians with reducible gauge symmetries describing the dynamics of both massless and massive fermionic fields of any spin. No off-shell constraints for the fields and gauge parameters are used from the very beginning. It is shown that the space of BRST cohomologies with a vanishing ghost number is determined only by the constraints corresponding to an irreducible Poincare-group representation. To illustrate the general construction, we obtain a Lagrangian description of fermionic fields with generalized spin (3/2,1/2) and (3/2,3/2) on a flat background containing the complete set of auxiliary fields and gauge symmetries.Comment: 41 pages, no figures, corrected typos, updated introduction, sections 5, 7.1, 7.2 with examples, conclusion with all basic results unchanged, corrected formulae (3.27), (7.138), (7.140), added dimensional reduction part with formulae (5.34)-(5.48), (7.8)-(7.10), (7.131)-(7.136), (7.143)-(7.164), added Refs. 52, 53, 54, examples for massive fields developed by 2 way

    LABOR PRODUCTIVITY AS A PRODUCTION EFFICIENCY FACTOR

    Get PDF
    El objetivo de esta investigación es estudiar el factor de eficiencia y la productividad laboral. En gran medida, el nivel de productividad laboral creció debido a la intensificación de la producción. Al mismo tiempo, según Rosstat, en agricultura, silvicultura y pesca solo hay un 8% de empleos altamente eficientes. Por lo tanto, el factor de intensificación de la producción se utiliza de manera insignificante. Es obvio que hay una necesidad de un componente innovador del crecimiento de la productividad laboral, por un lado, y la creación de nuevos empleos en las zonas rurales para los recursos laborales liberados, por otro lado. Aquí es necesario determinar los principales factores que afectan la productividad en las condiciones modernas, y justificar las propuestas para mejorarla.Of the goal of this investigation is to study the efficiency factor and labor productivity. To a large extent, the level of labor productivity grew due to the intensification of production. At the same time, according to Rosstat, in agriculture, forestry and fisheries there are only 8% of high-efficient jobs. Thus, the factor of production intensification is used insignificantly. It is obvious that there is a need for an innovative component of labor productivity growth on the one hand, and the creation of new jobs in rural areas for the released labor resources, on the other hand. Here it is necessary to determine the main factors affecting productivity in modern conditions, and to justify proposals to improve it.O objetivo desta investigacΜ§aΜƒo é estudar o fator de eficieΜ‚ncia e a produtividade do trabalho. Em grande medida, o nível de produtividade do trabalho aumentou devido aΜ€ intensificacΜ§aΜƒo da producΜ§aΜƒo. Ao mesmo tempo, segundo Rosstat, na agricultura, silvicultura e pesca, existem apenas 8% dos empregos de alta eficieΜ‚ncia. Assim, o fator de intensificacΜ§aΜƒo da producΜ§aΜƒo é usado de forma insignificante. É óbvio que é necessário um componente inovador do crescimento da produtividade do trabalho, por um lado, e a criacΜ§aΜƒo de novos empregos nas áreas rurais para os recursos liberados, por outro. Aqui é necessário determinar os principais fatores que afetam a produtividade nas condicΜ§oΜƒes modernas e justificar propostas para melhorá- la

    Closed geodesics in Alexandrov spaces of curvature bounded from above

    Full text link
    In this paper, we show a local energy convexity of W1,2W^{1,2} maps into CAT(K)CAT(K) spaces. This energy convexity allows us to extend Colding and Minicozzi's width-sweepout construction to produce closed geodesics in any closed Alexandrov space of curvature bounded from above, which also provides a generalized version of the Birkhoff-Lyusternik theorem on the existence of non-trivial closed geodesics in the Alexandrov setting.Comment: Final version, 22 pages, 2 figures, to appear in the Journal of Geometric Analysi

    БистСма гСмостаза Π² Π½ΠΎΡ€ΠΌΠ΅ ΠΈ ΠΏΡ€ΠΈ трансплантации ΠΏΠ΅Ρ‡Π΅Π½ΠΈ (ΠΎΠ±Π·ΠΎΡ€)

    Get PDF
    The review dwells on the problem of hemostatic disorders in patients undergoing liver transplantation and their correction in the perioperative period. The physiology of the hemostatic system, disorders of the blood coagulation system in patients at various stages of liver transplantation, correction of hemostatic disorders during and after orthotopic liver transplantation are discussed. Liver transplantation is performed in patients with liver diseases in the terminal stage of liver failure. At the same time, changes in the hemostatic system of these patients pose a significant risk of developing bleeding and/or thrombosis during and after liver transplantation. The hypothesis is suggested that the personalized correction of hemostasis disorder in liver transplantation should be based on considerating the nosological forms of the liver damage, mechanisms of development of recipient’s hemostatic disorders, and the stage of the surgery.ΠžΠ±Π·ΠΎΡ€ посвящСн ΠΏΡ€ΠΎΠ±Π»Π΅ΠΌΠ΅ Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΠΉ Π² систСмС гСмостаза ΠΈ ΠΈΡ… ΠΊΠΎΡ€Ρ€Π΅ΠΊΡ†ΠΈΠΈ Π² ΠΏΠ΅Ρ€ΠΈΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π΅ Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ², ΠΏΠΎΠ΄Π²Π΅Ρ€Π³Π°ΡŽΡ‰ΠΈΡ…ΡΡ трансплантации ΠΏΠ΅Ρ‡Π΅Π½ΠΈ. ΠžΠ±ΡΡƒΠΆΠ΄Π°ΡŽΡ‚ΡΡ: физиология систСмы гСмостаза; Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΡ Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΈ ΡΠ²Π΅Ρ€Ρ‚Ρ‹Π²Π°ΡŽΡ‰Π΅ΠΉ систСмы ΠΊΡ€ΠΎΠ²ΠΈ Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² Π½Π° Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… стадиях ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΈ трансплантации ΠΏΠ΅Ρ‡Π΅Π½ΠΈ; коррСкция Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΠΉ гСмостаза Π²ΠΎ врСмя ΠΈ послС ортотопичСской трансплантации ΠΏΠ΅Ρ‡Π΅Π½ΠΈ. Врансплантация ΠΏΠ΅Ρ‡Π΅Π½ΠΈ выполняСтся ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Π°ΠΌ с заболСваниями ΠΏΠ΅Ρ‡Π΅Π½ΠΈ Π² Ρ‚Π΅Ρ€ΠΌΠΈΠ½Π°Π»ΡŒΠ½ΠΎΠΉ стадии ΠΏΠ΅Ρ‡Π΅Π½ΠΎΡ‡Π½ΠΎ-ΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π½ΠΎΠΉ нСдостаточности. ΠŸΡ€ΠΈ этом измСнСния Π² систСмС гСмостаза этих Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… ΠΏΡ€Π΅Π΄ΡΡ‚Π°Π²Π»ΡΡŽΡ‚ Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹ΠΉ риск развития, ΠΊΠ°ΠΊ ΠΊΡ€ΠΎΠ²ΠΎΡ‚Π΅Ρ‡Π΅Π½ΠΈΠΉ, Ρ‚Π°ΠΊ ΠΈ Ρ‚Ρ€ΠΎΠΌΠ±ΠΎΠ·ΠΎΠ² Π²ΠΎ врСмя ΠΈ послС трансплантации ΠΏΠ΅Ρ‡Π΅Π½ΠΈ. ΠšΠΎΡ€Ρ€Π΅ΠΊΡ†ΠΈΡ Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΠΉ гСмостаза ΠΏΡ€ΠΈ трансплантации ΠΏΠ΅Ρ‡Π΅Π½ΠΈ Π΄ΠΎΠ»ΠΆΠ½Π° ΠΏΡ€ΠΎΡ…ΠΎΠ΄ΠΈΡ‚ΡŒ с ΡƒΡ‡Π΅Ρ‚ΠΎΠΌ нозологичСской Ρ„ΠΎΡ€ΠΌΡ‹ поврСТдСния ΠΏΠ΅Ρ‡Π΅Π½ΠΈ, ΠΌΠ΅Ρ…Π°Π½ΠΈΠ·ΠΌΠΎΠ² развития Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΠΉ гСмостаза Ρ€Π΅Ρ†ΠΈΠΏΠΈΠ΅Π½Ρ‚Π° ΠΈ этапа ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΈ

    MARKERS OF INFLAMMATION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND CARDIOVASCULAR PATHOLOGY

    Get PDF
    Objective: to estimate the levels of high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), tumor necrosis factor-a (TNF-Ξ±), and soluble TNF-Ξ± receptor type 1 (sTNF-R1) in patients with antiphospholipid syndrome (APS) and their association with cardiovascular pathology. Subjects and methods. Ninety-six patients, including 52 with primary APS and 44 with systemic lupus erythematosus and APS, were examined. A control group comprised 29 individuals without the signs of autoimmune disease. The levels of hsCRP, IL-6, TNF-Ξ±, sTNF-R1, antiphospholipid antibodies, and plasma lipids were studied; ultrasonography measuring the carotid intima-media complex (IMC), electrocardiography (ECG), echocardiography, and Holter ECG monitoring were made. Results. The concentrations of hsCRP, IL-6, TNF-Ξ±, and sTNF-R1 were significantly higher in the patient groups than in the controls (p < 0.05). Elevated sTNF-R1 concentrations were more common in angina pectoris than in its absence (OR = 2.13; 95% CI [1.51; 2.99]; p < 0.001). In patients with damage to the valvular apparatus, IL-6, TNF-Ξ±, and sTNF-R1 concentrations were significantly higher than those in patients without the defects (p = 0.02, 0.02, and 0.01, respectively). The levels of TNF-Ξ± and sTNF-R1 were significantly higher in hypertensive patients than those in non-hypertensives (p = 0.002 and p < 0.001; respectively). The blood concentration of TNF-Ξ± was significantly higher in patients having the risk factors and subclinical signs of atherosclerosis that that in those without the signs and risk factors of atherosclerosis (p < 0.05). Analysis showed a direct correlation between the levels of TNF-Ξ±, hsCRP, IL-6, and sTNF-R1 and an inverse correlation of those of IL-6 and TNF-Ξ± with the duration of posttrombosis (p < 0.05). A correlation was found between the concentrations of TNF-Ξ± and sTNF-R1, and IMC of the great arteries, as well as the cumulative coronary risk (p < 0.05). Conclusion. In patients with APS, the levels of all the test markers were significantly higher than those in the controls. An association was revealed between the values of TNF-Ξ± and sTNF-R1 and the risk factors and subclinical signs of atherosclerosis

    ΠœΠ΅ΡΡ‚ΠΎ Π²Π½ΡƒΡ‚Ρ€ΠΈΠ²Π΅Π½Π½ΠΎΠ³ΠΎ ΠΈΠΌΠΌΡƒΠ½ΠΎΠ³Π»ΠΎΠ±ΡƒΠ»ΠΈΠ½Π° ΠΏΡ€ΠΈ рСвматичСских заболСваниях

    Get PDF
    Therapy with intravenous human immunoglobulin (IVIG) was and continues to remain essential for a number of diseases. At the same time the evidence base for IVIG use is extremely small in rheumatology. Clinical experience shows that IVIG is effective in treating thrombocytopenic purpura, Guillain–Barre syndrome, and chronic inflammatory demyelinating polyneuropathy, which develop in the presence of rheumatic diseases, such as systemic lupus erythematosus, inflammatory myopathies, and antineutrophil cytoplasmic antibody-associated vasculitides. The review considers indications for the use of IVIG, its dosage regimen, benefits, and adverse reactions and analyzes the Russian and foreign literature on this issue.ВСрапия Π²Π½ΡƒΡ‚Ρ€ΠΈΠ²Π΅Π½Π½Ρ‹ΠΌ чСловСчСским ΠΈΠΌΠΌΡƒΠ½ΠΎΠ³Π»ΠΎΠ±ΡƒΠ»ΠΈΠ½ΠΎΠΌ (Π’Π’Π˜Π“) Π±Ρ‹Π»Π° ΠΈ ΠΏΡ€ΠΎΠ΄ΠΎΠ»ΠΆΠ°Π΅Ρ‚ ΠΎΡΡ‚Π°Π²Π°Ρ‚ΡŒΡΡ Π½Π΅ΠΎΠ±Ρ…ΠΎΠ΄ΠΈΠΌΠΎΠΉ ΠΏΡ€ΠΈ рядС Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ. Π’ Ρ‚ΠΎ ΠΆΠ΅ врСмя Π΄ΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΡŒΠ½Π°Ρ Π±Π°Π·Π° примСнСния Π’Π’Π˜Π“ Π² Ρ€Π΅Π²ΠΌΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΊΡ€Π°ΠΉΠ½Π΅ ΠΌΠ°Π»Π°. ΠšΠ»ΠΈΠ½ΠΈΡ‡Π΅ΡΠΊΠΈΠΉ ΠΎΠΏΡ‹Ρ‚ ΠΏΠΎΠΊΠ°Π·Ρ‹Π²Π°Π΅Ρ‚, Ρ‡Ρ‚ΠΎ Π’Π’Π˜Π“ эффСктивСн ΠΏΡ€ΠΈ тромбоцитопСничСской ΠΏΡƒΡ€ΠΏΡƒΡ€Π΅, синдромС ГийСна–БаррС ΠΈ хроничСской Π²ΠΎΡΠΏΠ°Π»ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ Π΄Π΅ΠΌΠΈΠ΅Π»ΠΈΠ½ΠΈΠ·ΠΈΡ€ΡƒΡŽΡ‰Π΅ΠΉ ΠΏΠΎΠ»ΠΈΠ½Π΅Π²Ρ€ΠΎΠΏΠ°Ρ‚ΠΈΠΈ, Ρ€Π°Π·Π²ΠΈΠ²ΡˆΠΈΡ…ΡΡ Π½Π° Ρ„ΠΎΠ½Π΅ рСвматичСских Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ, Ρ‚Π°ΠΊΠΈΡ… ΠΊΠ°ΠΊ систСмная красная Π²ΠΎΠ»Ρ‡Π°Π½ΠΊΠ°, Π²ΠΎΡΠΏΠ°Π»ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ ΠΌΠΈΠΎΠΏΠ°Ρ‚ΠΈΠΈ ΠΈ ассоциированныС с Π°Π½Ρ‚ΠΈΠ½Π΅ΠΉΡ‚Ρ€ΠΎΡ„ΠΈΠ»ΡŒΠ½Ρ‹ΠΌΠΈ цитоплазматичСскими Π°Π½Ρ‚ΠΈΡ‚Π΅Π»Π°ΠΌΠΈ васкулиты. Π’ ΠΎΠ±Π·ΠΎΡ€Π΅ рассмотрСны показания ΠΊ Π½Π°Π·Π½Π°Ρ‡Π΅Π½ΠΈΡŽ Π’Π’Π˜Π“, Ρ€Π΅ΠΆΠΈΠΌ дозирования, прСимущСства ΠΈ Π½Π΅ΠΆΠ΅Π»Π°Ρ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ Ρ€Π΅Π°ΠΊΡ†ΠΈΠΈ, ΠΏΡ€ΠΈΠ²Π΅Π΄Π΅Π½ Π°Π½Π°Π»ΠΈΠ· отСчСствСнной ΠΈ Π·Π°Ρ€ΡƒΠ±Π΅ΠΆΠ½ΠΎΠΉ Π»ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Ρ‹ ΠΏΠΎ Π΄Π°Π½Π½ΠΎΠΌΡƒ вопрос
    • …
    corecore